0H7R Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abeona Therapeutics Inc

Watchlist Manager

Watchlist

Price: 5.65 USD -4.4% Market Closed

Market Cap: $16B

A	Abeona Therapeutics Inc LSE:0H7R	US
M	Medline Inc NASDAQ:MDLN	US
N	National Grid PLC DUS:NNGF	UK

Profitability Summary

Abeona Therapeutics Inc's profitability score is 29/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

74%

Negative 3Y Average Gross Margin

-7%

Negative Operating Margin

-1 537%

Negative 3Y Average Operating Margin

-6 620%

Operating Margin is Increasing

-4 007% > -1 537%

Exceptional Net Margin

1 223%

Strong 3Y Average Net Margin

4 326%

Net Margin is Increasing

-2 579% > 1 223%

Negative Free Cash Flow Margin

-1 448%

Negative 3Y Average Free Cash Flow Margin

-6 354%

Free Cash Flow Margin is Increasing

-3 905% > -1 448%

Exceptional ROE

70%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-549%

Declining ROIC

-266% > -637%

View All

Hide

Collapse

29 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.